173 related articles for article (PubMed ID: 25776473)
1. Clinical significance of serum interleukin-18 (IL-18) levels in patients with gastric cancer.
Tas F; Tilgen Yasasever C; Karabulut S; Tastekin D; Duranyildiz D
Biomed Pharmacother; 2015 Mar; 70():19-23. PubMed ID: 25776473
[TBL] [Abstract][Full Text] [Related]
2. Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer.
Tas F; Yasasever CT; Karabulut S; Tastekin D; Duranyildiz D
Tumour Biol; 2015 Mar; 36(3):2097-103. PubMed ID: 25391430
[TBL] [Abstract][Full Text] [Related]
3. Circulating annexin A2 as a biomarker in gastric cancer patients: correlation with clinical variables.
Tas F; Tilgen Yasasever C; Karabulut S; Tastekin D; Duranyildiz D
Biomed Pharmacother; 2015 Feb; 69():237-41. PubMed ID: 25661364
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic role of serum interleukin-18 in gastric cancer patients.
Thong-Ngam D; Tangkijvanich P; Lerknimitr R; Mahachai V; Theamboonlers A; Poovorawan Y
World J Gastroenterol; 2006 Jul; 12(28):4473-7. PubMed ID: 16874857
[TBL] [Abstract][Full Text] [Related]
5. Expression and significance of intratumoral interleukin-12 and interleukin-18 in human gastric carcinoma.
Ye ZB; Ma T; Li H; Jin XL; Xu HM
World J Gastroenterol; 2007 Mar; 13(11):1747-51. PubMed ID: 17461482
[TBL] [Abstract][Full Text] [Related]
6. Levels of serum fibronectin as a biomarker in gastric cancer patients: Correlation with clinical diagnosis and outcome.
Tas F; Bilgin E; Karabulut S; Tastekin D; Duranyildiz D
Mol Clin Oncol; 2016 Apr; 4(4):655-659. PubMed ID: 27073685
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer.
Erturk K; Tastekin D; Serilmez M; Bilgin E; Bozbey HU; Vatansever S
Tumour Biol; 2016 Jan; 37(1):405-12. PubMed ID: 26219901
[TBL] [Abstract][Full Text] [Related]
8. Elevated circulating monocyte chemoattractant protein 1 (MCP-1/CCL-2) level may be an unfavorable predictive factor to platinum- and taxane-based combination chemotherapy in patients with gastric cancer.
Tas F; Karabulut S; Serilmez M; Karabulut M; Duranyildiz D
Cancer Chemother Pharmacol; 2016 Jan; 77(1):127-31. PubMed ID: 26499899
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of serum caveolin-1 levels in gastric cancer patients.
Tas F; Karabulut S; Erturk K; Duranyildiz D
Exp Oncol; 2018 Dec; 40(4):323-327. PubMed ID: 30593761
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of Serum Galectin-3 Levels in Gastric Cancer Patients.
Tas F; Bilgin E; Tastekin D; Erturk K; Duranyildiz D
J Gastrointest Cancer; 2016 Jun; 47(2):182-6. PubMed ID: 27038444
[TBL] [Abstract][Full Text] [Related]
11. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer.
Karabulut M; Alis H; Afsar CU; Karabulut S; Kocatas A; Oguz H; Aykan NF
Biomed Pharmacother; 2015 Jul; 73():140-6. PubMed ID: 26211595
[TBL] [Abstract][Full Text] [Related]
12. Preoperative serum interleukin-18 level as a postoperative prognostic marker in patients with gastric carcinoma.
Kawabata T; Ichikura T; Majima T; Seki S; Chochi K; Takayama E; Hiraide H; Mochizuki H
Cancer; 2001 Oct; 92(8):2050-5. PubMed ID: 11596019
[TBL] [Abstract][Full Text] [Related]
13. Serum IL-17 levels can be diagnostic for gastric cancer.
Karabulut M; Usul Afsar C; Serimez M; Karabulut S
J BUON; 2019; 24(4):1601-1609. PubMed ID: 31646815
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
[TBL] [Abstract][Full Text] [Related]
15. Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers?
Erturk K; Tastekin D; Bilgin E; Serilmez M; Bozbey HU; Sakar B
Biomed Pharmacother; 2016 Feb; 77():86-91. PubMed ID: 26796270
[TBL] [Abstract][Full Text] [Related]
16. Investigation on correlations of serum IL-26 with diagnosis and staging of gastric cancer.
Xue T; Yang J; Song P; Zhou G
J BUON; 2019; 24(1):215-220. PubMed ID: 30941972
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of interleukin-4 and interleukin-18 levels in aggressive non-Hodgkin's lymphoma patients.
Soydinc HO; Guney N; Basaran M; Duranyildiz D; Yasasever V
Genet Mol Res; 2016 Jul; 15(3):. PubMed ID: 27525895
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of serum leptin level in patients with gastric cancer.
Tas F; Karabulut S; Erturk K; Duranyildiz D
Eur Cytokine Netw; 2018 Jun; 29(2):52-58. PubMed ID: 30078770
[TBL] [Abstract][Full Text] [Related]
19. Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies.
De Vita F; Orditura M; Galizia G; Romano C; Infusino S; Auriemma A; Lieto E; Catalano G
Cancer; 1999 Nov; 86(10):1936-43. PubMed ID: 10570416
[TBL] [Abstract][Full Text] [Related]
20. Serum interleukin-6 levels reflect disease status of gastric cancer.
Wu CW; Wang SR; Chao MF; Wu TC; Lui WY; P'eng FK; Chi CW
Am J Gastroenterol; 1996 Jul; 91(7):1417-22. PubMed ID: 8678006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
